Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXK1YO
|
||||
Drug Name |
4-(5-{[2-(3-Nitro-phenyl)-3-oxo-2,3,4,5-tetrahydro-1H-benzo[c]azepin-4-ylamino]-methyl}-imidazol-1-ylmethyl)-benzonitrile
|
||||
Synonyms |
CHEMBL164116
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C28H24N6O3
|
||||
Canonical SMILES |
[O-][N+](=O)c1cccc(c1)N2Cc3ccccc3CC(NCc4cncn4Cc5ccc(cc5)C#N)C2=O
|
||||
InChI |
InChI=1S/C28H24N6O3/c29-14-20-8-10-21(11-9-20)17-32-19-30-15-26(32)16-31-27-12-22-4-1-2-5-23(22)18-33(28(27)35)24-6-3-7-25(13-24)34(36)37/h1-11,13,15,19,27,31H,12,16-18H2
|
||||
InChIKey |
WBCNUAHNRQZIKX-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.